User profiles for C. Varjú

Cecilia Varju

Professor of Medical school, University of Pecs, Hungary
Verified email at pte.hu
Cited by 1498

A comprehensive framework for navigating patient care in systemic sclerosis: a global response to the need for improving the practice of diagnostic and preventive …

LA Saketkoo, T Frech, C Varjú, R Domsic… - Best Practice & …, 2021 - Elsevier
Systemic sclerosis (SSc), the most lethal of rheumatologic conditions, is the cause of death
in >50% of SSc cases, led by pulmonary fibrosis followed by pulmonary hypertension and …

Exercise as a multi-modal disease-modifying medicine in systemic sclerosis: An introduction by The Global Fellowship on Rehabilitation and Exercise in Systemic …

…, T Frech, C Feghali-Bostwick, C Varjú… - Best practice & research …, 2021 - Elsevier
… , Janos Varga d , Malin Regardt a e , Anne-Marie Russell f g , Yasser Salam h , Kelly
Jensen i j k , Jennifer Mansour j k , Tracy Frech l , Carol Feghali-Bostwick m , Cecília Varjú n , …

Survival and causes of death in 366 Hungarian patients with systemic sclerosis

L Czirják, G Kumánovics, C Varjú, Z Nagy… - Annals of the …, 2008 - ard.bmj.com
C Varjú1, … . Increased C reactive protein and aminoterminal propeptide of type III procollagen
levels are unfavourable predictors of survival in systemic sclerosis (scleroderma). Clin Exp …

Prevalence and clinical associations of anti-Ku antibodies in patients with systemic sclerosis: a European EUSTAR-initiated multi-centre case–control study

…, S Čučnik, S Sodin-Semrl, L Czirják, C Varjú… - Annals of the …, 2008 - ard.bmj.com
Objectives: To determine the prevalence of anti-Ku antibodies in 625 patients with systemic
sclerosis (SSc) from six European rheumatological centres and to evaluate their clinical and …

Multi-Organ System Screening, Care, and Patient Support in Systemic Sclerosis

C Varjú, JD Pauling… - Rheumatic Disease …, 2023 - rheumatic.theclinics.com
… Cecília Varjú, MD, PhD Cecília Varjú … (c) Table 3 provides an overview of recurrent
anticipatory guidance and counseling essential in SSc care. …

The effect of physical exercise following acute disease exacerbation in patients with dermato/polymyositis

C Varjú, E Pethö, R Kutas, L Czirják - Clinical rehabilitation, 2003 - journals.sagepub.com
The effect of physical exercise following acute disease exacerbation in patients with dermato/polymyositis
- Cecília Varjú, Edit Pethö, Réka Kutas, László Czirják, 2003 …

Construct validity evaluation of the European Scleroderma Study Group activity index, and investigation of possible new disease activity markers in systemic sclerosis

…, G Kumánovics, T Czömpöly, D Simon, C Varjú… - …, 2010 - academic.oup.com
… a Change in patient-reported 17-area thickness score over 1 year; b change in skin symptoms
during last month; c change in MRSS over 1 year; d change in vascular symptoms during …

Clinical usefulness of measuring red blood cell distribution width in patients with systemic sclerosis

…, T Minier, Z Prohászka, L Czirják, C Varjú - …, 2014 - academic.oup.com
Objective. Red blood cell distribution width (RDW) is a biomarker quantifying the variability
of red blood cell size in peripheral blood. Elevated RDW has been found to be an …

Malignancies in patients with anti-RNA polymerase III antibodies and systemic sclerosis: analysis of the EULAR scleroderma trials and research cohort and possible …

…, J Hernandez, R Hesselstrand, C Varju… - The Journal of …, 2017 - jrheum.org
Objective. To analyze the characteristics of anti-RNA polymerase III antibodies (anti-RNAP3)−
positive patients with systemic sclerosis (SSc) in the European League Against …

[PDF][PDF] Phenotypes determined by cluster analysis and their survival in the prospective European scleroderma trials and research cohort of patients with systemic …

…, S Novak, L Czirjak, C Varju, C Chizzolini… - Arthritis & …, 2019 - Wiley Online Library
… Finally, we calculated the C- index for each Cox regression model (ie, the estimation of …
C- indexes were similar for the mostadjusted models: lcSSc versus dcSSc, cluster A versus …